RxDoctor Payments DataLook up a doctor →

Bruce Black, MD

Family Medicine · Madison, MSNPI 1730199290

Payments from drug & device makers

$16,920in general payments, 2019–2025

Across 1,082 payments — averaging $15.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • AstraZeneca$2K
  • Pfizer$1K
  • Lilly USA, LLC$966
  • Novo Nordisk$925
  • Merck$829
  • plus $8K from 51 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)220$3,306
AstraZeneca91$1,569
Pfizer86$1,328
Lilly USA, LLC82$966
Novo Nordisk61$925
Merck55$829
GSK57$784
Takeda Pharmaceuticals U.S.A., Inc.46$721
Johnson & Johnson40$540
Amarin Pharma, Inc.26$496
Boehringer Ingelheim26$410
Amgen(2 entities)25$399
Esperion Therapeutics, Inc.23$388
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC21$331
Phathom Pharmaceuticals, Inc.17$282
Tris Pharma Inc14$269
Teva Pharmaceuticals USA, Inc.15$236
Ironwood Pharmaceuticals, Inc11$205
Sumitomo Pharma America, Inc.12$202
Biohaven Pharmaceuticals, Inc.14$195
Biohaven Pharmaceutical Holding Company Ltd.10$183
Jazz Pharmaceuticals Inc.10$183
Astellas Pharma US Inc10$172
Kowa Pharmaceuticals America, Inc.9$167
Sunovion Pharmaceuticals Inc.8$150
Sanofi-aventis U.S. LLC7$117
Abbott5$110
Otsuka America Pharmaceutical, Inc.3$98
Lundbeck LLC4$98
Supernus Pharmaceuticals, Inc.6$98
GRT US Holding, Inc.1$95
Eisai Inc.5$78
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)4$77
Idorsia Pharmaceuticals US Inc5$76
Novartis4$70
Tolmar, Inc.4$70
Axsome Therapeutics, Inc.3$67
Genentech USA, Inc.4$58
Antares Pharma, Inc.2$47
Exact Sciences3$45
Ironshore Pharmaceuticals Inc.3$43
Xeris Pharmaceuticals, Inc.2$41
Amneal Pharmaceuticals LLC3$37
Upsher-smith Laboratories LLC2$36
E.r. Squibb & Sons, L.L.C.3$36
Corium, LLC3$36
Shield Therapeutics Inc2$35
Bayer2$32
Medtronic2$29
Neos Therapeutics, LP2$29
Shire North American Group Inc2$24
Nalpropion Pharmaceuticals LLC2$24
Promius Pharma LLC1$18
Vertex1$17
Nestle Healthcare Nutrition Inc.1$17
Nabriva Therapeutics, PLC1$15
Melinta Therapeutics, LLC1$12

How this compares

$16,920 in reported general payments places this provider in the 95th percentile of 971 family medicine providers in Mississippi.

See all family medicine providers in Mississippi

Medicare billing

Part B allowed, 2024
$251,687
Medicare patients
695
Services billed
5,874

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Madison

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →